Sana Biotechnology’s $189.75 Million Upsized Follow-On Offering

Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now